Kursmål for aktien: 31.93 $
Det gennemsnitlige kursmål for Aurora Cannabis Inc aktien er 31.93 $ hvilket viser forventningen til aktien indenfor de næste 12 mdr.
aktien er potentielt undervurderet, da kursmålet ligger under den aktiekurs. Aktien er undervurderet med 490,20 % Aktien forventes derfor at stige indenfor 12 mdr og kan derfor være en god investering, såfremt man kan regne med analytikernes kursmål. Der er dog andre faktorer, som er interessante at vurderere, inden et køb af aktien. Både nøgletal som Price-to-earnings, Price-to-sales og Price-to-Book har betydning for denne vurdering, men også virksomhedens sektor, industri og stabilitet i indtjening og kurs momentum og risiko er vigtig og alt det vurderer vi i TradeDesk.
Om Aurora Cannabis Inc
Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Læs mere om virksomheden